Related Experiment Video
Updated: Nov 26, 2025

08:18
Engineered Vascularized Muscle Flap
Published on: January 11, 2016
8.5K
Lumbar Perforator Flaps for Coverage of Extensive Defects With Osteomyelitis
Clara Schaffer1, David Guillier, Wassim Raffoul
1From the Plastic, Reconstructive and Hand Surgery Department, Lausanene University Hospital (Centre Hospitalier Universitaire Vaudois - CHUV), Lausanne, Switzerland.
Annals of Plastic Surgery
|December 11, 2020
Summary
Lumbar perforator flaps effectively cover soft tissue defects in chronic osteomyelitis cases. This reliable local option offers low morbidity and good cosmetic results for lumbar reconstruction.
Area of Science:
- Reconstructive surgery
- Orthopedic surgery
- Plastic surgery
Background:
- Lumbar osteomyelitis is a serious condition requiring appropriate treatment to prevent complications.
- Traditional treatments favored muscle or myocutaneous flaps for recurrent infections.
- Recent evidence highlights radical debridement and dead space obliteration as crucial.
Purpose of the Study:
- To evaluate the long-term outcomes of using lumbar perforator flaps for lumbar soft tissue defects in patients with chronic osteomyelitis.
- To assess the reliability and effectiveness of lumbar perforator flaps in this specific patient population.
Main Methods:
- Retrospective analysis of 7 consecutive patients (10 flaps) with extensive posterior midline defects (L2-S1).
- Defects resulted from tumor resection, vascular compromise, or debridement of neglected wounds.
- All patients had concomitant bone infection; infectious details and complications were recorded.
Main Results:
- Patients often had significant comorbidities.
- Eight flaps were propeller perforators, two were V-Y perforators; one required revision due to venous congestion.
- Complete healing occurred in 29 ± 17 days; no flap loss was observed with a mean follow-up of 20 months.
Conclusions:
- Lumbar perforator flaps are a dependable choice for reconstructing large lumbar soft tissue defects.
- These flaps demonstrate low donor site morbidity and acceptable cosmetic outcomes, even in the presence of chronic osteomyelitis.

